{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH", "hasEmail": "mailto:info@nih.gov"}, "description": "Blood substitutes have long been sought after, and artificial oxygen\t\t  carriers may soon become a reality. Despite increased safety of allogeneic\t\t  blood in terms of transmission of infectious diseases [1], avoiding allogeneic blood transfusions remains an important\t\t  goal in perioperative and intensive care medicine. This is because allogeneic\t\t  blood transfusions may cause immunosuppression with an increased incidence of\t\t  postoperative infections [2,3] and\t\t  may adversely affect outcome in intensive care [4], and\t\t  thus they remain a public concern [5].", "distribution": [{"@type": "dcat:Distribution", "description": "Visit the original government dataset for complete information, documentation, and data access.", "downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137238/", "mediaType": "text/html", "title": "Official Government Data Source"}], "identifier": "https://healthdata.gov/api/views/6iff-9rfa", "issued": "2025-07-14", "keyword": ["blood-substitutes", "hemoglobin-based", "nih", "oxygen-carriers", "transfusion-alternatives"], "landingPage": "https://healthdata.gov/d/6iff-9rfa", "modified": "2025-09-29", "programCode": ["009:048"], "publisher": {"@type": "org:Organization", "name": "National Institutes of Health"}, "theme": ["NIH"], "title": "Blood substitutes"}